SecBot SecBot
Institutional Cluster

VTGN

Vistagen Therapeutics, Inc.
BULLISH
Impact 5/10
Horizonweeks Processed5mo ago
Institutional cluster: 5 buyers, 0 sellers (bullish)
Actionable Insight ▲ Bullish

The concentrated buying by quant funds (RenTech, Two Sigma) and passive managers (Morgan Stanley, BofA) suggests a data-driven or index-related thesis rather than fundamental catalyst conviction. Monitor upcoming pipeline updates or regulatory milestones for VTGN, as the cluster may reflect anticipation of clinical trial results. The lack of analyst upgrades despite this buying warrants caution.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$0.5731
T+0 close · Jun 11, 2026 · via day close
Latest settled
−57.63%
T+60 · $0.2428
Vs SPY
−62.03%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $0.5731entry
  2. T+1 · 5mo ago +0.54%α +0.00% · $0.5762
  3. T+5 · 5mo ago +20.40%α +19.96% · $0.6900
  4. T+20 · 4mo ago −56.52%α −58.41% · $0.2492
  5. T+60 · 2mo ago −57.63%α −62.03% · $0.2428

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Five institutional investors, including Renaissance Technologies and Two Sigma, significantly increased their positions in Vistagen Therapeutics during Q3 2025, with aggregate holdings rising from $0.4M to $3.0M. This cluster of buying activity, dominated by quant and passive funds, suggests a shared thesis around the company's pipeline prospects despite the stock's small $21M market cap and predominantly neutral analyst consensus.

Key Financial Metrics

Direction
accumulating
Buy Value
$3.0M
Sell Value
$0.00
Net Flow
$2.6M

Institutional Positions

Net institutional flow: $2.6M

▲ Buyers (5)

InstitutionActionChangePosition ValueValue Δ
Renaissance TechnologiesDOUBLED+942%$1.5M$1.4M
Two SigmaDOUBLED+223.5%$1.0M$849.0K
Dimensional Fund AdvisorsADD+56.9%$241.0K$155.0K
Morgan StanleyDOUBLED+126.7%$98.0K$73.0K
Bank of AmericaDOUBLED+926%$123.0K$116.0K

Key Facts

  • 5 institutional buyers accumulated $3.0M in VTGN during Q3 2025, up from $0.4M previously
  • Renaissance Technologies doubled its position by 942%, now holding $1.5M
  • Two Sigma doubled its position by 223.5%, now holding $1.0M
  • No institutional sellers were identified in the cluster
  • Market cap is $21M with 0% analyst bullishness (7 Hold, 1 Sell, 2 Strong Sell)

Financial Impact

5 institutions accumulated $2.6M in net new positions, with total holdings reaching $3.0M, representing approximately 14% of the company's $21M market cap

institutional ownershipfloat

Risk Factors

  • 13F data has a 45-day reporting lag; positions may have been partially or fully unwound since quarter-end
  • Small market cap ($21M) means even modest institutional flows can create outsized signals
  • Quant-driven buying may be algorithmic and not reflect fundamental conviction
  • Predominantly neutral/sell analyst consensus (0% bullish) contradicts institutional buying pattern

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-VTGN-2025-Q3

US Market Status

Market Closed · Opens in 6h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026